These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 15881330

  • 41. N-octyl-O-sulfate chitosan-modified liposomes for delivery of docetaxel: preparation, characterization, and pharmacokinetics.
    Qu G, Wu X, Yin L, Zhang C.
    Biomed Pharmacother; 2012 Feb; 66(1):46-51. PubMed ID: 22264883
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Transepithelial transport of morphine and mannitol in Caco-2 cells: the influence of chitosans of different molecular weights and degrees of acetylation.
    Dale O, Nilsen T, Olaussen G, Tvedt KE, Skorpen F, Smidsrød O, Vårum KM.
    J Pharm Pharmacol; 2006 Jul; 58(7):909-15. PubMed ID: 16805950
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Chitosan-coated liposomes for intracellular oligonucleotides delivery: characteristics and cell uptake behavior.
    Wang WX, Gao JQ, Liang WQ.
    Drug Deliv; 2011 Apr; 18(3):208-14. PubMed ID: 21254940
    [Abstract] [Full Text] [Related]

  • 46. One-step preparation of chitosan-coated cationic liposomes by an improved supercritical reverse-phase evaporation method.
    Otake K, Shimomura T, Goto T, Imura T, Furuya T, Yoda S, Takebayashi Y, Sakai H, Abe M.
    Langmuir; 2006 Apr 25; 22(9):4054-9. PubMed ID: 16618144
    [Abstract] [Full Text] [Related]

  • 47. Chitosan-coated nanoliposome as vitamin E carrier.
    Liu N, Park HJ.
    J Microencapsul; 2009 May 25; 26(3):235-42. PubMed ID: 18798045
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone.
    Wittaya-areekul S, Kruenate J, Prahsarn C.
    Int J Pharm; 2006 Apr 07; 312(1-2):113-8. PubMed ID: 16490331
    [Abstract] [Full Text] [Related]

  • 50. Investigation of pluronic and PEG-PE micelles as carriers of meso-tetraphenyl porphine for oral administration.
    Sezgin Z, Yuksel N, Baykara T.
    Int J Pharm; 2007 Mar 06; 332(1-2):161-7. PubMed ID: 17055200
    [Abstract] [Full Text] [Related]

  • 51. Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery.
    Li N, Zhuang C, Wang M, Sun X, Nie S, Pan W.
    Int J Pharm; 2009 Sep 08; 379(1):131-8. PubMed ID: 19559775
    [Abstract] [Full Text] [Related]

  • 52. Development and in vivo evaluation of a new oral nanoparticulate dosage form for leuprolide based on polyacrylic acid.
    Iqbal J, Vigl C, Moser G, Gasteiger M, Perera G, Bernkop-Schnürch A.
    Drug Deliv; 2011 Aug 08; 18(6):432-40. PubMed ID: 21557716
    [Abstract] [Full Text] [Related]

  • 53. Specific permeability modulation of intestinal paracellular pathway by chitosan-poly(isobutylcyanoacrylate) core-shell nanoparticles.
    Bravo-Osuna I, Vauthier C, Chacun H, Ponchel G.
    Eur J Pharm Biopharm; 2008 Jun 08; 69(2):436-44. PubMed ID: 18395430
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Influence of cyclodextrins and chitosan, separately or in combination, on glyburide solubility and permeability.
    Zerrouk N, Corti G, Ancillotti S, Maestrelli F, Cirri M, Mura P.
    Eur J Pharm Biopharm; 2006 Apr 08; 62(3):241-6. PubMed ID: 16226882
    [Abstract] [Full Text] [Related]

  • 56. Controlled transdermal delivery of model drug compounds by MEMS microneedle array.
    Xie Y, Xu B, Gao Y.
    Nanomedicine; 2005 Jun 08; 1(2):184-90. PubMed ID: 17292077
    [Abstract] [Full Text] [Related]

  • 57. Effect of N-betainate and N-piperazine derivatives of chitosan on the paracellular transport of mannitol in Caco-2 cells.
    Korjamo T, Holappa J, Taimisto S, Savolainen J, Järvinen T, Mönkkönen J.
    Eur J Pharm Sci; 2008 Oct 02; 35(3):226-34. PubMed ID: 18675903
    [Abstract] [Full Text] [Related]

  • 58. Chitosan nanoparticles encapsulated vesicular systems for oral immunization: preparation, in-vitro and in-vivo characterization.
    Jain S, Sharma RK, Vyas SP.
    J Pharm Pharmacol; 2006 Mar 02; 58(3):303-10. PubMed ID: 16536896
    [Abstract] [Full Text] [Related]

  • 59. Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system.
    Han HK, Shin HJ, Ha DH.
    Eur J Pharm Sci; 2012 Aug 15; 46(5):500-7. PubMed ID: 22522117
    [Abstract] [Full Text] [Related]

  • 60. Mucoadhesive and penetration enhancement properties of three grades of hyaluronic acid using porcine buccal and vaginal tissue, Caco-2 cell lines, and rat jejunum.
    Sandri G, Rossi S, Ferrari F, Bonferoni MC, Zerrouk N, Caramella C.
    J Pharm Pharmacol; 2004 Sep 15; 56(9):1083-90. PubMed ID: 15324476
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.